1379338-74-5Relevant articles and documents
FUSED RING DERIVATIVE AS A2A RECEPTOR INHIBITOR
-
, (2020/08/09)
Disclosed are a compound represented by formula (I) or a pharmaceutically acceptable salt thereof, and an application of the compound or slat in preparation of drugs for treating diseases related to an A2A receptor.
PYRIDO[3,4-B]PYRAZINE DERIVATIVES AS SYK INHIBITORS
-
, (2014/02/15)
A compound of formula (I): or a salt thereof; which is an inhibitor of spleen tyrosine kinase (Syk) and therefore potentially of use in treating diseases resulting from inappropriate activation of mast cells, macrophages, and B-cells and related inflammatory responses and tissue damage, for instance inflammatory disease and/or allergic disorders, and in cancer therapy, specifically heme malignancies, and autoimmune conditions.
SUBSTITUTED PYRIDOPYRAZINES AS NOVEL SYK INHIBITORS
-
, (2014/05/08)
Provided are pyridopyrazine compounds of formula (1), pharmaceutical compositions thereof and methods of use therefore, wherein R1, R2, R3, R4 and m are as defined in the specification.
PYRIDO[3,4-B]PYRAZINE DERIVATIVES AS SYK INHIBITORS
-
, (2012/10/07)
A compound of formula (I) or a salt thereof; which is an inhibitor of spleen tyrosine kinase (Syk) and therefore potentially of use in treating diseases resulting from inappropriate activation of mast cells, macrophages, and B-cells and related inflammatory responses and tissue damage, for instance inflammatory disease and/or allergic disorders, and in cancer therapy, specifically heme malignancies, and autoimmune conditions.
SUBSTITUTED PYRIDOPYRAZINES AS NOVEL SYK INHIBITORS
-
, (2013/02/27)
Provided are pyridopyrazine compounds of formula (I), pharmaceutical compositions thereof and methods of use therefore, wherein R1, R2, R3, R4 and m are as defined in the specification.
SUBSTITUTED PYRIDOPYRAZINES AS NOVEL SYK INHIBITORS
-
, (2013/02/27)
Provided are certain pyridopyrazine compounds, pharmaceutical compositions thereof and methods of use therefor.